54. Hydrodynamic delivery of Sleeping Beauty transposons to canine liver via balloon catheters

Hackett, Perry B.; Urness, Myra; Bell, Jason; Aronovich, Elena L.; Olson, Eric L; Hunter, David W.; McIvor, Scott

doi:10.1016/j.ymgme.2009.10.071

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fig. (3) illustrates the two types of pressure profiles we have encountered in our hydrodynamic deliveries of plasmids with transposons to dog liver using balloon catheters [87]. Profiles similar to that in panel b of Fig.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and Safety of Sleeping Beauty Transposon-Mediated Gene Transfer in Preclinical Animal Studies

Hackett¹,

Aronovich²,

Hunter³

et al. 2011

CGT

Self Cite

View full text Add to dashboard Cite

Sleeping Beauty (SB) transposons have been effective in delivering therapeutic genes to treat certain diseases in mice. Hydrodynamic gene delivery of integrating transposons to 5–20% of the hepatocytes in a mouse results in persistent elevated expression of the therapeutic polypeptides that can be secreted into the blood for activity throughout the animal. An alternative route of delivery is ex vivo transformation with SB transposons of hematopoietic cells, which then can be reintroduced into the animal for treatment of cancer. We discuss issues associated with the scale-up of hydrodynamic delivery to the liver of larger animals as well as ex vivo delivery. Based on our and others’ experience with inefficient delivery to larger animals, we hypothesize that impulse, rather than pressure, is a critical determinant of the effectiveness of hydrodynamic delivery. Accordingly, we propose some alterations in delivery strategies that may yield efficacious levels of gene delivery in dogs and swine that will be applicable to humans. To ready hydrodynamic delivery for human application we address a second issue facing transposons used for gene delivery regarding their potential to “re-hop” from one site to another and thereby destabilize the genome. The ability to correct genetic diseases through the infusion of DNA plasmids remains an appealing goal.

show abstract

Section: Introductionmentioning

confidence: 99%